Cargando…

Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction

INTRODUCTION: Exposure to secondhand smoke (SHS) is associated with occult obstructive lung disease as evident by abnormal airflow indices representing small airway disease despite having preserved spirometry (normal forced expiratory volume in 1 s-to-forced vital capacity ratio, FEV(1)/FVC). The si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arjomandi, Mehrdad, Zeng, Siyang, Geerts, Jeroen, Stiner, Rachel K, Bos, Bruce, van Koeverden, Ian, Keene, Jason, Elicker, Brett, Blanc, Paul D, Gold, Warren M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942438/ https://www.ncbi.nlm.nih.gov/pubmed/29755755 http://dx.doi.org/10.1136/bmjresp-2018-000284

Ejemplares similares

Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease
por: Blagev, Denitza P, et al.
Publicado: (2020)

DNA methylation is associated with airflow obstruction in patients living with HIV
por: Hernandez Cordero, Ana I, et al.
Publicado: (2021)

Small airway determinants of airflow limitation in chronic obstructive pulmonary disease
por: Polosukhin, Vasiliy V, et al.
Publicado: (2021)

Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25–75/FVC) in COPD
por: Abston, Eric, et al.
Publicado: (2017)

Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022)

Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12
por: Jackson, Victoria E, et al.
Publicado: (2016)

Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study
por: Heraganahally, Subash S, et al.
Publicado: (2021)

Small airway function measured using forced expiratory flow between 25% and 75% of vital capacity and its relationship to airflow limitation in symptomatic ever-smokers: a cross-sectional study
por: Alobaidi, Nowaf Y, et al.
Publicado: (2022)

Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study
por: Wang, Yuanyuan, et al.
Publicado: (2020)

Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake
por: Epton, Michael, et al.
Publicado: (2018)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease
por: Huang, Jeffrey T-J, et al.
Publicado: (2012)

Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD
por: Lewis, Amy, et al.
Publicado: (2011)

Aclidinium inhibits human lung fibroblast to myofibroblast transition
por: Milara, Javier, et al.
Publicado: (2011)

Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
por: Yorke, J, et al.
Publicado: (2010)

Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema
por: Mimae, Takahiro, et al.
Publicado: (2014)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society
por: McNulty, William, et al.
Publicado: (2014)

The impact of chronic obstructive pulmonary disease on intensive care unit admission and 30-day mortality in patients undergoing colorectal cancer surgery: a Danish population-based cohort study
por: Platon, Anna Maria, et al.
Publicado: (2014)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial
por: Deslee, Gaëtan, et al.
Publicado: (2014)

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
por: Di Stefano, Antonino, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary
por: Leidy, N K, et al.
Publicado: (2014)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
por: Buhl, Roland, et al.
Publicado: (2015)

Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study
por: Skovhus Prior, Thomas, et al.
Publicado: (2015)

Comparison of oxygen uptake during cycle ergometry with and without functional electrical stimulation in patients with COPD: protocol for a randomised, single-blind, placebo-controlled, cross-over trial
por: Medrinal, Clément, et al.
Publicado: (2016)

Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study
por: McKeever, Tricia M, et al.
Publicado: (2016)

Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial)
por: Chatwin, M, et al.
Publicado: (2016)

Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial
por: Frith, Peter A, et al.
Publicado: (2015)

Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD
por: Suh, Eui-Sik, et al.
Publicado: (2015)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Productivity losses in chronic obstructive pulmonary disease: a population-based survey
por: Erdal, Marta, et al.
Publicado: (2014)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD
por: Boutou, Afroditi K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_edrepc9ass7bu625rqh9l9mmes